Our monthly report on AI, ML, DL, and NLP in healthcare looks at who, what, where, and how the use of artificial intelligence is changing healthcare for the better. We will bring you some of the latest news and product information along with thought leader posts and our AI playlist of episodes from Healthcare NOW Radio.
In the News
North America AI in Healthcare Market size exceeded USD 1.15 billion in 2020 and is predicted to witness over 44.2% CAGR from 2021 to 2027
Artificial intelligence (AI) is the broad-ranging division of computer science involved in developing smart machines competent in executing tasks that ordinarily need human intelligence. AI technologies are enhancing ongoing developments in the medical field, modern business, and everyday life practices in healthcare. Artificial intelligence in healthcare can support healthcare providers in multiple sectors of patient care and organizational management processes. Different applications of healthcare AI such as early diagnosis, lessen therapeutic errors, increase patient safety, and decision support are accelerating the market demand. Read the forecast.
Caris’ Precision Oncology Alliance Welcomes The Ohio State University Comprehensive Cancer Center
The Caris Precision Oncology Alliance (@carisls) includes 59 cancer centers and academic institutions. These institutions have early access to the extensive database and artificial intelligence platform within Caris to establish evidence-based standards for cancer profiling and molecular testing in oncology. By leveraging the comprehensive genomic, transcriptomic and proteomic profiling available through the Caris Molecular Intelligence® platform, Caris seeks to provide this network with the ability to prioritize therapeutic options and determine which clinical trial opportunities may benefit their patients.
Rockley Photonics announces Bioptx™ biomarker sensing platform for professional healthcare, including first-of-its-kind non-invasive, continuous biosensing wristband
Rockley Photonics Holdings Limited (@RockleyPhotonic) announced the Bioptx™ platform of biomarker sensing products and solutions for the medical and healthcare market. The Bioptx sensing platform will include a range of hardware and software solutions that enable non-invasive, continuous, and real-time monitoring of multiple biomarkers, from a wearable biosensing wristband to cloud analytics and artificial intelligence (AI). Rockley also plans to offer additional cloud-based subscription services that enhance the capabilities of the biosensing platform.
SkyPoint Cloud Launches SkyPoint Profile, Customer 360 Solution
SkyPoint Cloud (SkyPoint) (@skypointcloud), the privacy-first customer data and artificial intelligence (AI) platform that enables consumer, financial services and healthcare brands to build deeper relationships with their customers and patients, announced the launch of SkyPoint Profile. SkyPoint Profile is a customer 360 solution that uses AI to create unique, unified customer profiles from multiple data silos, allowing companies to understand a customer’s full journey for better engagement and outcomes.
Francisco Partners to Acquire IBM’s Healthcare Data and Analytics Assets
IBM (NYSE: IBM) and Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, announced that the companies have signed a definitive agreement under which Francisco Partners will acquire healthcare data and analytics assets from IBM that are currently part of the Watson Health business. The assets acquired by Francisco Partners include extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings.
Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools
Twist Bioscience Corporation (@TwistBioscience), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Eleven Therapeutics (@eleventx), a company leading the AI revolution in nucleic acid therapies, announced that they have created a replicon tool that could be used for studying viral genome replication and antiviral drug screening as well as vaccine and therapeutic development.
The Potential for Artificial Intelligence to Improve Healthcare Supply Chain Management By Matt Stewart, CEO, RiseNow (@WeAreRiseNow) – As artificial intelligence (AI) continues to evolve into a must-have technology in almost every industry, healthcare organizations have continued to expand and accelerate their AI strategies. A recent Optum survey found that more than half of healthcare executives expect AI will begin delivering tangible cost savings within three years at about a 90% increase – which is certainly a lofty goal.
Exploring the Future of Artificial Intelligence in Cardiovascular Medicine: A Discussion with Mayo Clinic’s Dr. Demilade Adedinsewo
Artificial intelligence (AI) is transforming the practice of medicine — with cardiology at the forefront of this paradigm shift. Recent studies have shown that AI-enhanced electrocardiograms (ECGs) can detect a variety of heart conditions. Demilade A. Adedinsewo, M.B., Ch.B., M.P.H., is a non-invasive cardiologist, assistant professor of medicine, Women’s Health Scholar, and director of research for the Women’s Heart Clinic and Cardiovascular Disease Fellowship program at Mayo Clinic in Florida. With deep interest in the application of digital tools in cardiovascular disease management, Dr. Adedinsewo is advancing the integration of AI-enabled technologies into the clinical practice at the intersection of women’s heart health, cardiovascular disease prevention, and cardiovascular health disparities.
AI at Upcoming Events
ViVE – March 6-9 in Miami
AI’s Power Play: Leveraging the Advantage
The rise of machines in all industries has come with both promise and fear as we see AI taking over more and more tasks traditionally handled by humans. Promise is outplaying fear as AI has proven itself as a talented healthcare recruit to aid clinical decision making, research and backend operations, to name a few. What will this advanced technology really deliver in the next year – and will we leverage the advantage it provides us or miss this scoring opportunity?
HIMSS – March 14-18 in Orlando
Session Category: Data & Information – Artificial Intelligence and Machine Learning
HIMSS22 education sessions are led by world-renowned healthcare and innovation thought leaders and explore top-of-mind issues and challenges. Best of all, they are available for continuing education credits. If you are interested in learning more about AI in healthcare, 52 sessions are found in the category filter.